Bruce D. Howard

2.8k total citations
64 papers, 2.3k citations indexed

About

Bruce D. Howard is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Bruce D. Howard has authored 64 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 30 papers in Cellular and Molecular Neuroscience and 15 papers in Genetics. Recurrent topics in Bruce D. Howard's work include Neuroscience and Neuropharmacology Research (23 papers), Venomous Animal Envenomation and Studies (10 papers) and Cellular transport and secretion (7 papers). Bruce D. Howard is often cited by papers focused on Neuroscience and Neuropharmacology Research (23 papers), Venomous Animal Envenomation and Studies (10 papers) and Cellular transport and secretion (7 papers). Bruce D. Howard collaborates with scholars based in United States, Australia and Netherlands. Bruce D. Howard's co-authors include Lawrence Toll, Cameron B. Gundersen, Timothy A. Denton, Jijun Wan, Robert W. Baloh, Joanna C. Jen, Irwin Tessman, J. F. Wernicke, William P. Melega and R H Ng and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Bruce D. Howard

63 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce D. Howard United States 29 1.4k 959 520 316 281 64 2.3k
Takehiko Amano Japan 22 1.6k 1.1× 1.1k 1.1× 141 0.3× 275 0.9× 346 1.2× 43 2.5k
Kyozo Hayashi Japan 32 1.6k 1.1× 882 0.9× 891 1.7× 255 0.8× 257 0.9× 175 3.1k
Tomiko Asano Japan 35 2.7k 1.9× 1.2k 1.2× 198 0.4× 109 0.3× 582 2.1× 104 3.6k
Mitsuyoshi Toyosato Japan 12 2.6k 1.8× 1.7k 1.8× 115 0.2× 216 0.7× 138 0.5× 14 3.4k
Stephan Grissmer Germany 36 4.8k 3.3× 2.3k 2.4× 624 1.2× 130 0.4× 121 0.4× 89 5.9k
Armen S. Manoukian Canada 16 1.9k 1.3× 637 0.7× 353 0.7× 309 1.0× 382 1.4× 24 3.7k
L. Austin Australia 27 1.4k 1.0× 897 0.9× 141 0.3× 144 0.5× 362 1.3× 82 2.5k
Adrienne S. Gordon United States 35 2.5k 1.7× 1.8k 1.9× 183 0.4× 151 0.5× 419 1.5× 77 4.2k
Kimon J. Angelides United States 29 1.8k 1.3× 1.2k 1.2× 142 0.3× 237 0.8× 558 2.0× 58 2.9k
Takayoshi Kuno Japan 35 2.7k 1.8× 691 0.7× 119 0.2× 118 0.4× 673 2.4× 110 3.6k

Countries citing papers authored by Bruce D. Howard

Since Specialization
Citations

This map shows the geographic impact of Bruce D. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce D. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce D. Howard more than expected).

Fields of papers citing papers by Bruce D. Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce D. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce D. Howard. The network helps show where Bruce D. Howard may publish in the future.

Co-authorship network of co-authors of Bruce D. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce D. Howard. A scholar is included among the top collaborators of Bruce D. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce D. Howard. Bruce D. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adam, Emma, et al.. (2024). Detection of levamisole and its metabolites in horses after oral levamisole administration over seven days. Journal of the American Veterinary Medical Association. 262(12). 1632–1638.
2.
Rogers, Linda, et al.. (2009). Chemoradiation in Advanced Vulval Carcinoma. International Journal of Gynecological Cancer. 19(4). 745–751. 14 indexed citations
3.
Vries, Boukje de, Hafsa Mamsa, Anine H Stam, et al.. (2009). Episodic Ataxia Associated With EAAT1 Mutation C186S Affecting Glutamate Reuptake. Archives of Neurology. 66(1). 97–101. 99 indexed citations
4.
Zheng, Shuang, et al.. (2002). The fetal and neonatal brain protein neuronatin protects PC12 cells against certain types of toxic insult. Developmental Brain Research. 136(2). 101–110. 17 indexed citations
5.
Howard, Bruce D., et al.. (2002). Wnt-1 has multiple effects on the expression of glutamate transporters. Neurochemistry International. 42(4). 345–351. 6 indexed citations
6.
Zheng, Shuang, et al.. (2000). Wnt-1 inhibits nerve growth factor-induced differentiation of PC12 cells by preventing the induction of some but not all late-response genes. Molecular Brain Research. 77(2). 232–245. 31 indexed citations
7.
Zheng, Shuang, et al.. (1999). Wnt Signaling Induces GLT‐1 Expression in Rat C6 Glioma Cells. Journal of Neurochemistry. 73(3). 1012–1023. 31 indexed citations
8.
Yeh, Jason S., Shuang Zheng, & Bruce D. Howard. (1998). Impaired differentiation of HPRT-deficient dopaminergic neurons: A possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome. Journal of Neuroscience Research. 53(1). 78–85. 35 indexed citations
9.
Boado, Rubén J., et al.. (1996). Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter. Molecular Brain Research. 37(1-2). 297–303. 68 indexed citations
10.
Wu, C. Fangyun & Bruce D. Howard. (1995). K252a-potentiation of EGF-induced neurite outgrowth from PC12 cells is not mimicked or blocked by other protein kinase activators or inhibitors. Developmental Brain Research. 86(1-2). 217–226. 10 indexed citations
11.
Howard, Bruce D., et al.. (1994). Contrasting Morphological Changes in PC12 Flat Cells Expressing Two Different Forms of Exogenous Oncogenic Ras. Experimental Cell Research. 211(1). 59–67. 2 indexed citations
12.
Wu, C. Fangyun, et al.. (1993). K252a potentiates epidermal growth factor‐induced differentiation of PC12 cells. Journal of Neuroscience Research. 36(5). 539–550. 13 indexed citations
14.
Andersen, Julie K., et al.. (1990). 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Resistant, Flat‐Cell PC12 Variants Having a Partial Loss of Transformed Phenotype. Journal of Neurochemistry. 55(2). 559–567. 16 indexed citations
15.
Dudley, Mark W., et al.. (1990). The Interaction of the Beta-Haloethyl Benzylamines, Xylamine, and DSP-4 with Catecholaminergic Neurons. The Annual Review of Pharmacology and Toxicology. 30(1). 387–403. 34 indexed citations
16.
Howard, Bruce D., et al.. (1990). Covalent labeling of the cocaine‐sensitive catecholamine transporter. Journal of Neuroscience Research. 26(2). 149–158. 11 indexed citations
17.
Helmke, Steve M. & Bruce D. Howard. (1987). Fractionation and Reconstitution of the Sarcoplasmic Reticulum Ca2+Pump Solubilized and Stabilized by CHAPS/Lipid Micelles. PubMed. 7(1). 1–22. 5 indexed citations
18.
Helmke, Steve M. & Bruce D. Howard. (1986). Mechanism of Inhibition of Calcium Uptake into Sarcoplasmic Reticulum by Notexin, a Neurotoxic and Myotoxic Polypeptide. PubMed. 6(3). 239–253. 3 indexed citations
19.
Melega, William P. & Bruce D. Howard. (1981). Choline and acetylcholine metabolism in PC12 secretory cells. Biochemistry. 20(15). 4477–4483. 28 indexed citations
20.
Howard, Bruce D., Wilson C.‐S. Wu, & Cameron B. Gundersen. (1976). Antagonism of botulinum toxin by theophylline. Biochemical and Biophysical Research Communications. 71(1). 413–415. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026